The First Affiliated Hospital Of Soochow University
Clinical trials sponsored by The First Affiliated Hospital Of Soochow University, explained in plain language.
-
Weekly vs daily shot race to stop bleeding after transplant
Disease control Not yet recruitingThis study tests whether a weekly injection (romiplostim) works as well as a daily injection (rhTPO) to help platelets recover after a donor stem cell transplant. Platelets are blood cells that prevent bleeding, and slow recovery after transplant increases bleeding and infection …
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Apr 02, 2026 02:42 UTC
-
New hope for blood cancer patients: experimental combo challenges standard chemo
Disease control Not yet recruitingThis study compares two treatment approaches for adults newly diagnosed with acute myeloid leukemia (AML), a serious blood cancer. Researchers want to see if a new combination of three drugs works better and is safer than the current standard chemotherapy. The trial will enroll 2…
Phase: PHASE3 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Scientists stack therapies in 'Sandwich' attack on tough leukemia
Disease control Not yet recruitingThis study is testing a new multi-step treatment plan for adolescents and adults with B-cell acute lymphoblastic leukemia (B-ALL). The goal is to see if combining immunotherapy, a patient's own stem cell transplant, and a dual-target CAR-T cell therapy can better control the dise…
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New Two-Pronged attack on returning ovarian cancer begins testing
Disease control Not yet recruitingThis study is testing a new combination treatment for women whose ovarian cancer has returned but still responds to platinum-based chemotherapy. It first combines a new two-in-one immunotherapy drug with standard chemotherapy, then switches to a maintenance pill called olaparib. …
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC
-
New hope for High-Risk leukemia: testing a gentler bridge to cure
Disease control Not yet recruitingThis study is for adults with a high-risk type of acute myeloid leukemia (AML) who are in remission and planning a stem cell transplant. It compares two different treatments given before the transplant to help keep the cancer from coming back. One treatment uses a newer drug comb…
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC
-
New cell therapy aims to shield patients from agonizing transplant side effect
Prevention Not yet recruitingThis study is testing if a single infusion of a cell therapy called Amimestrocel can prevent severe, painful mouth sores in patients undergoing a stem cell transplant. About 22 adult patients in China will receive the infusion 1-2 days before their transplant. Researchers will mo…
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Prevention
Last updated Mar 30, 2026 14:28 UTC